Your trusted destination for CME, CPD & Medical Education across the Middle East.
The MENA Microbiome Conference 2026: From Biomarker Discovery to Microbiota-Based Therapeutics explores emerging research and clinical advances in the human microbiome and its role in health and disease. The conference brings together researchers and healthcare professionals to examine the development of microbiome-based biomarkers, diagnostics, and therapeutic approaches.
The MENA Microbiome Conference 2026 provides a platform for exploring the rapidly evolving field of microbiome science, from fundamental research to clinical applications. The program highlights advances in microbiome research, biomarker discovery, microbial profiling, and the relationship between the microbiota and human health. Participants can learn about emerging microbiota-based therapeutics and their potential applications across different areas of medicine. The conference also addresses developments in translational research, precision medicine, and innovative approaches for utilizing microbiome data in patient care. Through expert presentations and scientific discussions, the event encourages knowledge exchange and collaboration among researchers, clinicians, and other professionals working in microbiome-related fields.
Exploring the impact of microbial balance on female reproductive outcomes and disease prevention.
Understanding the maternal microbiome's influence during pregnancy and its effects on maternal-fetal health.
Tracking the development and foundational role of the microbiome from birth through early childhood.
The role of breast milk, formula, and early diet in shaping the infant microbiome.
Investigating the complex bidirectional communication between gut microbiota and neurological health.
Latest research on how the gut microbiome affects systemic organ function, including the liver and heart.
Identifying microbial signatures for accurate disease diagnosis and prognosis.
Developing targeted clinical interventions such as probiotics, prebiotics, and fecal microbiota transplantation.
Accredited Group Learning Activity (Category 1) approved for a maximum of 12 hours.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
